Nantahala Capital Management »

Scpharmaceuticals shares owned by Nantahala Capital Management

Quarter-by-quarter ownership of Scpharmaceuticals (SCPH) shares owned by Nantahala Capital Management from 13F filings

Historical chart of Nantahala Capital Management investment in Scpharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Scpharmaceuticals held by Nantahala Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Scpharmaceuticals by Nantahala Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $4.9M 861k 5.67
2025-06-30 $3.8M 995k 3.81
2025-03-31 $2.6M 995k 2.63
2024-12-31 $3.5M 1.0M 3.54
2024-09-30 $3.4M 750k 4.56

More positions owned by Nantahala Capital Management

Ishares Tr Russell 2000 Etf Put Option (IWM)
Edwards Lifesciences Put Option (EW)
Hilton Grand Vacations (HGV)
Establishment Labs Holdings Ord (ESTA)
Peloton Interactive Cl A Com (PTON)
Spdr Series Trust S&p Biotech Put Option (XBI)
Herbalife Com Shs (HLF)
Soleno Therapeutics (SLNO)
Ban (TBBK)
Uniqure Nv SHS (QURE)
Teva Pharmaceutical Inds Sponsored Ads Call Option (TEVA)
Viatris Call Option (VTRS)
Abivax Sa Sponsored Ads (ABVX)
Xtant Med Hldgs Com New (XTNT)
Fulcrum Therapeutics (FULC)

View all positions for Nantahala Capital Management

Top funds holding Scpharmaceuticals

OrbiMed Advisors
Rubric Capital Management
Weiss Asset Management LP[1
BlackRock
Vanguard Group
Tudor Investment Corporation
Morgan Stanley
Luther King Capital Management Corporation
Hsbc Holdings
Glazer Capital
Alpine Associates Management
Newtyn Management
Geode Capital Management
Nantahala Capital Management
State Street Corporation

View all funds holding Scpharmaceuticals